GFG Capital LLC Invests $214,000 in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

GFG Capital LLC purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 2,747 shares of the company’s stock, valued at approximately $214,000.

Other large investors also recently bought and sold shares of the company. Jennison Associates LLC lifted its position in GE HealthCare Technologies by 49.4% during the 4th quarter. Jennison Associates LLC now owns 1,208,830 shares of the company’s stock valued at $93,467,000 after acquiring an additional 399,961 shares during the period. South Dakota Investment Council lifted its position in GE HealthCare Technologies by 272.1% during the 4th quarter. South Dakota Investment Council now owns 98,262 shares of the company’s stock valued at $7,598,000 after acquiring an additional 71,857 shares during the period. US Bancorp DE lifted its position in GE HealthCare Technologies by 83.4% during the 4th quarter. US Bancorp DE now owns 146,524 shares of the company’s stock valued at $11,329,000 after acquiring an additional 66,638 shares during the period. Cambridge Investment Research Advisors Inc. raised its holdings in GE HealthCare Technologies by 23.7% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 97,127 shares of the company’s stock worth $7,510,000 after buying an additional 18,634 shares during the last quarter. Finally, Global Assets Advisory LLC purchased a new position in GE HealthCare Technologies in the first quarter worth about $4,273,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the transaction, the chief technology officer now owns 67,300 shares of the company’s stock, valued at $5,296,510. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC traded down $1.65 during trading hours on Tuesday, hitting $83.94. 1,463,582 shares of the company’s stock traded hands, compared to its average volume of 3,050,885. The business’s fifty day moving average price is $80.28 and its two-hundred day moving average price is $83.31. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.05. The firm has a market capitalization of $38.32 billion, a P/E ratio of 24.54, a P/E/G ratio of 3.00 and a beta of 1.17. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.92 earnings per share. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were given a $0.03 dividend. The ex-dividend date was Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies’s payout ratio is currently 3.51%.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Bank of America decreased their target price on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Stifel Nicolaus began coverage on shares of GE HealthCare Technologies in a research note on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target for the company. The Goldman Sachs Group began coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price target for the company. Finally, Mizuho reduced their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. Five equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $95.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.